Capacity scale-ups to drive Epigral's ₹5,000 crore target by FY31: CMD

Specialty chemicals manufacturer Epigral is targeting revenue of Rs 5,000 crore by 2030-31, driven by upcoming production scale-ups in CPVC Resin and Epichlorohydrin (ECH), a senior company executive said. The company expects to reach Rs 2,900 crore in revenue this fiscal year following revenue of Rs 2,5002,530 crore in 2026.